Molecular Animal Biotechnology Laboratory, Szent Istvan University, Godollo, Hungary.
Theriogenology. 2012 Nov;78(8):1774-86. doi: 10.1016/j.theriogenology.2012.06.017. Epub 2012 Aug 24.
Pluripotent stem cells have the capacity to divide indefinitely and to differentiate into all somatic cells and tissue lines. They can be genetically manipulated in vitro by knocking genes in or out, and therefore serve as an excellent tool for gene function studies and for the generation of models for some human diseases. Since 1981, when the first mouse embryonic stem cell (ESC) line was generated, many attempts have been made to generate pluripotent stem cell lines from other species. Comparative characterization of ESCs from different species would help us to understand differences and similarities in the signaling pathways involved in the maintenance of pluripotency and the initiation of differentiation, and would reveal whether the fundamental mechanism controlling self-renewal of pluripotent cells is conserved across different species. This report gives an overview of research into embryonic and induced pluripotent stem cells in the rabbit, an important nonrodent species with considerable merits as an animal model for specific diseases. A number of putative rabbit ESC and induced pluripotent stem cell lines have been described. All of them expressed stem cell-associated markers and maintained apparent pluripotency during multiple passages in vitro, but none have been convincingly proven to be fully pluripotent in vivo. Moreover, as in other domestic species, the markers currently used to characterize the putative rabbit ESCs are suboptimal because recent studies have revealed that they are not always specific to the pluripotent inner cell mass. Future validation of rabbit pluripotent stem cells would benefit greatly from a validated panel of molecular markers specific to pluripotent cells of the developing rabbit embryos. Using rabbit-specific pluripotency genes may improve the efficiency of somatic cell reprogramming for generating induced pluripotent stem cells and thereby overcome some of the challenges limiting the potential of this technology.
多能干细胞具有无限分裂和分化为所有体细胞和组织谱系的能力。它们可以通过敲除或敲入基因在体外进行遗传操作,因此是研究基因功能和生成某些人类疾病模型的优秀工具。自 1981 年首次生成小鼠胚胎干细胞 (ESC) 系以来,人们已经尝试了许多方法来从其他物种中生成多能干细胞系。不同物种的 ESC 的比较特征分析将有助于我们理解维持多能性和启动分化过程中涉及的信号通路的差异和相似之处,并揭示控制多能细胞自我更新的基本机制是否在不同物种中得到保守。本报告概述了兔胚胎和诱导多能干细胞的研究,兔是一种重要的非啮齿类动物模型,在特定疾病的动物模型方面具有很大的优势。已经描述了一些推定的兔 ESC 和诱导多能干细胞系。它们都表达了与干细胞相关的标记物,并在体外多次传代过程中保持明显的多能性,但没有一种在体内被证明是完全多能的。此外,与其他家畜一样,目前用于表征推定的兔 ESC 的标记物并不理想,因为最近的研究表明它们并不总是多能性内细胞团的特异性标记物。未来对兔多能干细胞的验证将大大受益于一组针对发育中的兔胚胎多能细胞的特异性、经过验证的分子标记物。使用兔特异性的多能性基因可能会提高体细胞重编程生成诱导多能干细胞的效率,从而克服限制该技术潜力的一些挑战。